Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration

Precious O Idogun; Mindy C Ward; Yeshanew Teklie; Wilhelmine Wiese-Rometsch; Joel Baker

doi:10.7759/cureus.14853

Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration

Cureus. 2021 May 5;13(5):e14853. doi: 10.7759/cureus.14853.

Authors

Precious O Idogun¹, Mindy C Ward¹, Yeshanew Teklie¹, Wilhelmine Wiese-Rometsch¹, Joel Baker¹

Affiliation

¹ Florida State University College of Medicine Internal Medicine Residency, Sarasota Memorial Hospital, Sarasota, USA.

Abstract

A few individuals are believed to have developed immune thrombocytopenia (ITP) following the administration of the coronavirus disease 2019 (COVID-19) vaccine. This phenomenon has been reported in a few case reports and also in some recent news articles. In this report, we discuss a case of a 54-year-old Caucasian female who presented to the emergency room with life-threatening thrombocytopenia in the setting of de novo ITP following COVID-19 vaccine administration. Due to the relapsing nature of ITP, it is unclear if the patient has achieved complete remission of the disease.

Keywords: adverse event; covid 19; itp; thrombocytopenia; vaccination.

Publication types

Case Reports